Leone Patterson

2021

In 2021, Leone Patterson earned a total compensation of $2.9M as Former President and Chief Financial Officer at Avalanche Biotechnologies, a 33% decrease compared to previous year.

Compensation breakdown

Option Awards$2,605,404
Salary$262,536
Other$15,500
Total$2,883,440

Patterson received $2.6M in option awards, accounting for 90% of the total pay in 2021.

Patterson also received $262.5K in salary and $15.5K in other compensation.

Rankings

In 2021, Leone Patterson's compensation ranked 4,588th out of 12,415 executives tracked by ExecPay. In other words, Patterson earned more than 63.0% of executives.

ClassificationRankingPercentile
All
4,588
out of 12,415
63rd
Division
Manufacturing
1,901
out of 5,505
66th
Major group
Chemicals And Allied Products
794
out of 2,375
67th
Industry group
Drugs
708
out of 2,096
66th
Industry
Biological Products, Except Diagnostic Substances
180
out of 449
60th

Pay ratio

Leone Patterson's Pay$2,883,440
Median Employee's Pay$188,229
Pay Ratio

15

to 1

In 2021, the annual total compensation of Leone Patterson was $2,883,440.

The annual total compensation of the median employee at Avalanche Biotechnologies was $188,229.

The ratio of Leone Patterson's pay to the pay of median employee was therefore 15 to one.

Source: SEC filing on April 26, 2022.

Patterson's colleagues

We found nine more compensation records of executives who worked with Leone Patterson at Avalanche Biotechnologies in 2021.

2021

Laurent Fischer

Avalanche Biotechnologies

Chief Executive Officer

2021

Christopher DeRespino

Avalanche Biotechnologies

Chief Financial Officer

2021

Angela Thedinga

Avalanche Biotechnologies

Chief Technology Officer

2021

Kishor Soparkar

Avalanche Biotechnologies

Chief Operating Officer

2021

Julie Clark

Avalanche Biotechnologies

Chief Medical Officer

2021

Brigit Riley

Avalanche Biotechnologies

Chief Scientific Officer

2021

Rupert D'Souza

Avalanche Biotechnologies

Chief Financial Officer

2021

Thomas Leung

Avalanche Biotechnologies

Chief Financial Officer

2021

Jack Thrift

Avalanche Biotechnologies

Chief Financial Officer

News

In-depth

You may also like